Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Central Nervous System Neoplasms

• PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
• A Study of Avutometinib for People With Solid Tumor Cancers
• B7-H3-CAR T Cells for Pediatric CNS Tumors
• A Phase 2 Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors
• Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation
• Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer
• Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors or Meningiomas Expressing SST2A
• Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations
• Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations
• The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors
• Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors
• Niraparib in Tumors Metastatic to the CNS
• CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
• A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Patients With ALK Fusion-Positive Solid or CNS Tumors
• Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
• Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
• Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
• RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors
• Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy
• LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)
• Study to Find the Appropriate Dose of a New Gadolinium-based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions
• Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors
• Mapping Draining Lymph Nodes in CNS Malignancies
• A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
• Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors
• StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord
• AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery
• ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
• A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
• INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies
• Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia
• Nivolumab and Pomalidomide in Treating Patients With Relapsed or Refractory Central Nervous System Diffuse Large B Cell Lymphoma or Primary Vitreoretinal Diffuse Large B Cell Lymphoma
• Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
• Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas
• REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma
• Volitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors
• Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery
• Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Detecting Lactate and Bicarbonate in Participants With Central Nervous System Tumors
• SGT-53 in Children With Recurrent or Progressive CNS Malignancies
• SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
• Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma
• Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
• Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow)
• A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors
• Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors
• Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
• Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
• Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
• Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
• Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
• Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
• Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
• Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
• COZMOS:Phase I/Ib Trial of Combined 5'Azacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain/Solid Tumors
• Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
• A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma
• Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors
• Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types
• Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
• Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
• Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
• Dual Time Point FDG PET-MR Imaging Optimization for the Evaluation of Glioblastoma
• Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
• Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
• Durvalumab in Pediatric and Adolescent Patients
• Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
• Indocyanine Green for Central Nervous System Tumors
• A Study of Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFR
• Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
• A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children
• Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors
• Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults
• Study of BLZ-100 in Pediatric Subjects With CNS Tumors
• Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
• Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System
• Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
• Phase I Dose Escalation Study of Topotecan and Pazopanib in Children With Recurrent/Refractory Solid Tumours
• Retrospective Study of MRI in Pediatric Patients
• Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
• VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors
• Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies
• Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors
• Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
• The Use of 5-aminolevulinic Acid (ALA) as an Intraoperative Tumor Marker for Resection of Pediatric Central Nervous System (CNS) Tumors
• Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma （PCNSL）
• p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
• Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab
• STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain
• Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors
• Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma
• Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors
• Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma
• Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
• Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
• Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma
• Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
• Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy
• Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
• Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme
• Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy
• Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
• Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma
• The Role of Bevacizumab in the Treatment of Radiation Necrosis in Children With Central Nervous System Tumors
• High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy
• Bevacizumab in Recurrent Grade II and III Glioma
• PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors
• Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours
• Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas
• Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
• Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
• Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
• Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
• Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma
• Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & Temozolomide
• Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
• Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
• Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme
• Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma
• Studying Fentanyl in Patients With Cancer
• Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
• Cilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung Cancer
• Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
• Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System
• Methionine PET/CT Studies In Patients With Cancer
• Standard Radiation Therapy, Higher-Dose Radiation Therapy, or Chemotherapy in Treating Older Patients With Glioblastoma Multiforme
• Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery
• Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
• A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors
• ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors
• MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma
• Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma
• Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL
• Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
• Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma
• Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
• Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
• Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy
• Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System
• Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma
• Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors
• Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy
• Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
• MT2004-30: Tomotherapy for Solid Tumors
• Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
• Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma
• Temozolomide in Treating Patients With Recurrent High-Grade Glioma
• Rosiglitazone in Treating Patients With Pituitary Tumors
• Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors
• Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma
• Temozolomide in Treating Patients With Invasive Pituitary Tumors
• Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
• MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer
• CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
• Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
• Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors
• Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors
• Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment
• Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors
• Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the Brain
• Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas
• VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma
• Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma
• High-Dose Methotrexate in Treating Young Patients With Solid Tumors
• Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma
• Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
• Enzastaurin in Treating Young Patients With Refractory Primary CNS Tumors
• Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
• Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
• Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme
• Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA
• Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma
• Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy
• Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors
• Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases
• Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade Glioma
• Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment
• Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain
• Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia
• O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy
• Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
• Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma
• Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin
• Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
• Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases
• Clinical Studies of Gemcitabine-Oxaliplatin
• Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma
• Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma
• Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma
• BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain
• Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
• Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors
• Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma
• Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
• Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
• Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma
• Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma
• Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer
• Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma
• Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma
• Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma
• Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
• ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma
• Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer
• Vatalanib in Treating Patients With Recurrent or Progressive Meningioma
• A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients
• EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients
• Temozolomide in Treating Patients With Low-Grade Glioma
• Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
• Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors
• Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
• Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors
• Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain
• High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma
• Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors
• Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas
• Etoposide in Treating Young Patients With Relapsed Ependymoma
• Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
• Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors
• Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery
• Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas
• Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
• O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors
• Radiation Therapy Followed By Combination Chemotherapy in Treating Young Patients With Supratentorial Primitive Neuroectodermal Tumors
• Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas
• Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas
• Melphalan With BBBD in Treating Patients With Brain Malignancies
• Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas
• A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors
• Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme
• Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme
• Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors
• Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme
• Radiation Therapy or Temozolomide in Treating Patients With Gliomas
• Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas
• Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors
• Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma
• High Light and Low Light Dose PDT in Glioma
• Temozolomide and Radiation Therapy in Treating Patients With Gliomas
• Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors
• Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
• Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma
• Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
• Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
• AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme
• Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
• Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme
• Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma
• VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors
• Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors
• Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas
• Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
• Hyperbaric Oxygen Therapy in Treating Patients With Radiation Necrosis of the Brain
• Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma
• Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme
• Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer
• Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
• Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor
• Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT
• Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
• High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma
• High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas
• Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
• Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas
• CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas
• Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen
• Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor
• Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors
• Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT
• Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
• Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
• Talampanel in Treating Patients With Recurrent High-Grade Glioma
• Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma
• Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma
• Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme
• Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
• Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer
• Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
• Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer
• Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases
• Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
• Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma
• Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
• Sirolimus in Treating Patients With Glioblastoma Multiforme
• Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
• Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma
• Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain
• Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy
• Imatinib Mesylate in Treating Patients With Gliomas
• ABT-751 in Treating Young Patients With Refractory Solid Tumors
• CC-5013 in Treating Patients With Recurrent Glioma
• SarCNU in Treating Patients With Recurrent Malignant Glioma
• Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas
• Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain
• Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors
• Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors
• Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma
• Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
• Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy
• Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma
• Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
• Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
• Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma
• Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme
• Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer
• Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors
• Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the Brain
• Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors
• Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma
• Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
• CCI-779 in Treating Patients With Malignant Glioma
• Taurolidine in Treating Patients With Recurrent or Progressive Glioma
• Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme
• Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma
• Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors
• Lobradimil and Carboplatin in Treating Children With Brain Tumors
• Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma
• Radiation Therapy in Treating Patients With Glioblastoma
• Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas
• Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma
• ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse
• SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors
• Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer
• Karenitecin in Treating Patients With Recurrent Malignant Glioma
• Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma
• Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme
• Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
• Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors
• Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma
• Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme
• Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm
• Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors
• Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma
• Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer
• Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
• Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
• Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma
• Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme
• Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
• Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
• Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor
• Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
• Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Immunotoxin Therapy in Treating Patients With Malignant Glioma
• Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma
• Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma
• SU5416 in Treating Children With Recurrent or Progressive Brain Tumors
• Busulfan in Treating Children and Adolescents With Refractory CNS Cancer
• Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma
• Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
• EMD 121974 in Treating Patients With Progressive or Recurrent Glioma
• Fenretinide in Treating Patients With Recurrent Malignant Glioma
• Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma
• Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
• Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma
• Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors
• Temozolomide in Treating Patients With Brain Metastases
• Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors
• Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma
• Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma
• Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma
• Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme
• Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma
• Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors
• Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma
• Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas
• Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma
• Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma
• Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme
• O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma
• SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy
• Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas
• Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma
• DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas
• Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
• Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors
• Temozolomide in Treating Patients With Recurrent Malignant Glioma
• Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor
• Carmustine in Treating Patients With Recurrent Malignant Glioma
• Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery
• Procarbazine in Treating Patients With Recurrent Brain Tumor
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
• Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
• Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
• Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma
• Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS
• Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors
• IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma
• Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas
• Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse
• O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors
• Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma
• Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
• CCI-779 in Treating Patients With Advanced Solid Tumors
• High-dose ICE With Amifostine
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma
• Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma
• Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
• Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
• Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas
• Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma
• Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma
• Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
• Antineoplaston Therapy in Treating Patients With Meningioma
• Antineoplaston Therapy in Treating Patients With Ependymoma
• Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
• Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
• Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme
• Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma
• Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma
• Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System
• Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma
• Temozolomide in Treating Patients With Progressive Low-Grade Glioma
• Temozolomide in Treating Patients With Anaplastic Oligodendroglioma
• Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme
• Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas
• Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors
• Antineoplaston Therapy in Treating Children With Brain Tumors
• Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme
• Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme
• Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas
• Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma
• Topotecan in Treating Patients With Recurrent Brain Tumors
• Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain
• Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer
• Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
• Irinotecan in Treating Patients With Recurrent Malignant Glioma
• SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
• Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors
• Vinorelbine in Treating Children With Recurrent or Refractory Cancers
• Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
• Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors
• Biological Therapy in Treating Patients With Glioblastoma Multiforme
• Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma
• High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors
• Irinotecan in Treating Patients With Recurrent Glioma
• Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma
• Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors
• Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma
• Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma
• Chemotherapy in Treating Patients With Recurrent Malignant Glioma
• O(6)-Benzylguanine in Treating Patients With Malignant Glioma
• Combination Chemotherapy in Treating Children With Progressive Brain Tumors
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer
• Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas
• Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
• Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma
• Docetaxel in Treating Children With Recurrent Solid Tumors
• Gene Therapy in Treating Patients With Primary Brain Tumors
• Combination Chemotherapy for Patients With Brain Cancer
• Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
• Melphalan in Patients With Neoplastic Meningitis
• Carboplatin in Patients With Progressive Gliomas
• Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors
• Suramin in Treating Patients With Recurrent Primary Brain Tumors
• Radiation Therapy in Treating Patients With Brain Cancer
• Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors
• Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
• Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
• Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
• Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors
• Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors
• Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors